These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30536880)

  • 1. Diacylglycerol kinase α-selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines.
    Yamaki A; Akiyama R; Murakami C; Takao S; Murakami Y; Mizuno S; Takahashi D; Kado S; Taketomi A; Shirai Y; Goto K; Sakane F
    J Cell Biochem; 2019 Jun; 120(6):10043-10056. PubMed ID: 30536880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel diacylglycerol kinase α-selective inhibitor, CU-3, induces cancer cell apoptosis and enhances immune response.
    Liu K; Kunii N; Sakuma M; Yamaki A; Mizuno S; Sato M; Sakai H; Kado S; Kumagai K; Kojima H; Okabe T; Nagano T; Shirai Y; Sakane F
    J Lipid Res; 2016 Mar; 57(3):368-79. PubMed ID: 26768655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where do substrates of diacylglycerol kinases come from? Diacylglycerol kinases utilize diacylglycerol species supplied from phosphatidylinositol turnover-independent pathways.
    Sakane F; Mizuno S; Takahashi D; Sakai H
    Adv Biol Regul; 2018 Jan; 67():101-108. PubMed ID: 28918129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitic acid- and/or palmitoleic acid-containing phosphatidic acids are generated by diacylglycerol kinase α in starved Jurkat T cells.
    Murakami Y; Murakami C; Hoshino F; Lu Q; Akiyama R; Yamaki A; Takahashi D; Sakane F
    Biochem Biophys Res Commun; 2020 May; 525(4):1054-1060. PubMed ID: 32184022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined inhibition/silencing of diacylglycerol kinase α and ζ simultaneously and synergistically enhances interleukin-2 production in T cells and induces cell death of melanoma cells.
    Takao S; Akiyama R; Sakane F
    J Cell Biochem; 2021 May; 122(5):494-506. PubMed ID: 33399248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ritanserin analogs that display DGK isoform specificity.
    Granade ME; Manigat LC; Lemke MC; Purow BW; Harris TE
    Biochem Pharmacol; 2022 Mar; 197():114908. PubMed ID: 34999054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Pathways: Targeting Diacylglycerol Kinase Alpha in Cancer.
    Purow B
    Clin Cancer Res; 2015 Nov; 21(22):5008-12. PubMed ID: 26420856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diacylglycerol kinase alpha suppresses tumor necrosis factor-alpha-induced apoptosis of human melanoma cells through NF-kappaB activation.
    Yanagisawa K; Yasuda S; Kai M; Imai S; Yamada K; Yamashita T; Jimbow K; Kanoh H; Sakane F
    Biochim Biophys Acta; 2007 Apr; 1771(4):462-74. PubMed ID: 17276726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Era of Diacylglycerol Kinase, Phosphatidic Acid and Phosphatidic Acid-Binding Protein.
    Sakane F; Hoshino F; Murakami C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Roles of Diacylglycerol Kinase α in Cancer Cell Proliferation and Apoptosis.
    Sakane F; Hoshino F; Ebina M; Sakai H; Takahashi D
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual activities of ritanserin and R59022 as DGKα inhibitors and serotonin receptor antagonists.
    Boroda S; Niccum M; Raje V; Purow BW; Harris TE
    Biochem Pharmacol; 2017 Jan; 123():29-39. PubMed ID: 27974147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of subtype-specific activators and inhibitors for diacylglycerol kinase.
    Hayashi D; Tsumagari R; Liu K; Ueda S; Yamanoue M; Sakane F; Shirai Y
    J Biochem; 2019 Jun; 165(6):517-522. PubMed ID: 30715374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diacylglycerol kinase inhibitor R59022-induced autophagy and apoptosis in the neuronal cell line NG108-15.
    Takita T; Konuma T; Hanazato M; Inoue H
    Arch Biochem Biophys; 2011 May; 509(2):197-201. PubMed ID: 21338572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope Mapping of Antidiacylglycerol Kinase α Monoclonal Antibody DaMab-2.
    Sano M; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2019 Feb; 38(1):8-11. PubMed ID: 30648914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells.
    Du X; Jiang Y; Qian W; Lu X; Walsh JP
    Biochem J; 2001 Jul; 357(Pt 1):275-82. PubMed ID: 11415460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diacylglycerol kinase alpha activity promotes survival of CD4+ 8+ double positive cells during thymocyte development.
    Outram SV; Crompton T; Merida I; Varas A; Martinez-A C
    Immunology; 2002 Apr; 105(4):391-8. PubMed ID: 11985659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not expecting the unexpected: diacylglycerol kinase alpha as a cancer target.
    Bhat KP; Aldape K
    Cancer Discov; 2013 Jul; 3(7):726-7. PubMed ID: 23847350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway.
    Takeishi K; Taketomi A; Shirabe K; Toshima T; Motomura T; Ikegami T; Yoshizumi T; Sakane F; Maehara Y
    J Hepatol; 2012 Jul; 57(1):77-83. PubMed ID: 22425622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers.
    Dominguez CL; Floyd DH; Xiao A; Mullins GR; Kefas BA; Xin W; Yacur MN; Abounader R; Lee JK; Wilson GM; Harris TE; Purow BW
    Cancer Discov; 2013 Jul; 3(7):782-97. PubMed ID: 23558954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and Epitope Mapping of Anti-Diacylglycerol Kinase α Monoclonal Antibody DaMab-8 for Immunohistochemical Analyses.
    Sano M; Kaneko MK; Suzuki H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2020 Feb; 39(1):1-5. PubMed ID: 31099705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.